Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,017 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

NCT03775850

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +35 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Chattanooga, Tennessee, United States
View Trial Details
Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

NCT03507452

Conditions
Adenoma, Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated), Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, +15 more
Locations
  • National Cancer Institute - Maryland Bethesda, Maryland, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • HUS, Meilahden sairaala Helsinki, Finland
  • Nederlands Kanker Instituut Amsterdam, Netherlands
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

NCT02983045

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • UCSD, Moores Cancer Center La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Denver Denver, Colorado, United States
View all 58 locations
View Trial Details
Completed

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

NCT01705184

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Caen - Centre François Baclesse Caen, France
  • Caen - CHU Côte de Nacre Caen, France
  • Centre Hospitalier Chauny, France
View Trial Details

Related conditions